Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.lincolnpharma.com | |
Market Cap | 623.33 Cr. | |
Enterprise Value(EV) | 613.63 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 33.63 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 9.25 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.90 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 233.98 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 1.33 | Calculated using Price: 311.00 |
Dividend Yield | 0.48 | Period Ending 2022-03 |
No. of Shares Subscribed | 2.00 Cr. | 20,029,728 Shares |
FaceValue | 10 | |
Company Profile | ||
Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way. |
1 Day |
|
-2.37% |
1 Week |
|
-7.84% |
1 Month |
|
-9.32% |
3 Month |
|
+5.84% |
6 Month |
|
+4.07% |
1 Year |
|
-11.69% |
2 Year |
|
+38.59% |
5 Year |
|
+25.43% |
10 Year |
|
+621.58% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 10.83 | 14.32 | 19.49 | 17.29 | 16.63 | 19.75 | 17.67 | 18.32 | 17.35 | |
Return on Capital Employed (%) | 11.48 | 15.91 | 21.18 | 18.51 | 19.05 | 22.50 | 22.30 | 24.90 | 24.29 | |
Return on Assets (%) | 4.10 | 5.77 | 8.87 | 9.40 | 10.09 | 12.80 | 12.33 | 13.48 | 13.31 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 99 | 111 | 141 | 192 | 224 | 269 | 313 | 366 | 433 | 469 | |
Non Curr. Liab. | 26 | 33 | 34 | 32 | 25 | 28 | 43 | 26 | 11 | 11 | |
Curr. Liab. | 131 | 114 | 100 | 99 | 113 | 100 | 80 | 95 | 111 | 124 | |
Minority Int. | 4 | 3 | 0 | 0 | 0 | 0 | 0 | ||||
Equity & Liab. | 260 | 262 | 275 | 324 | 363 | 399 | 437 | 487 | 555 | 603 | |
Non Curr. Assets | 111 | 81 | 128 | 134 | 136 | 159 | 174 | 160 | 182 | 189 | |
Curr. Assets | 149 | 181 | 147 | 190 | 227 | 239 | 263 | 328 | 373 | 414 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 260 | 262 | 275 | 324 | 363 | 399 | 437 | 487 | 555 | 603 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 210 | 266 | 400 | 360 | 361 | 366 | 386 | 424 | 472 | 487 | |
Other Income | 2 | 7 | 7 | 3 | 5 | 6 | 11 | 6 | 10 | 17 | |
Total Income | 213 | 273 | 408 | 363 | 366 | 372 | 398 | 430 | 482 | 503 | |
Total Expenditure | -190 | -240 | -360 | -314 | -308 | -299 | -321 | -337 | -377 | -400 | |
PBIDT | 23 | 33 | 48 | 50 | 58 | 73 | 77 | 93 | 105 | 103 | |
Interest | -7 | -8 | -10 | -7 | -5 | -4 | -2 | -2 | -1 | -1 | |
Depreciation | -4 | -5 | -5 | -6 | -6 | -7 | -7 | -8 | -8 | -9 | |
Taxation | -2 | -5 | -9 | -9 | -12 | -13 | -16 | -21 | -27 | -26 | |
Exceptional Items | |||||||||||
PAT | 10 | 15 | 24 | 28 | 35 | 49 | 51 | 62 | 69 | 67 | |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 11 | 15 | 24 | 28 | 35 | 49 | 51 | 62 | 69 | 67 | |
Adjusted EPS | 7 | 9 | 15 | 14 | 17 | 24 | 26 | 31 | 35 | 34 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -16 | 5 | 25 | 45 | 25 | 27 | 53 | 75 | 69 | 76 | |
Cash Fr. Inv. | -16 | 1 | 7 | -42 | -25 | -12 | -18 | -31 | -64 | -78 | |
Cash Fr. Finan. | 29 | -11 | -32 | -3 | 0 | -11 | -36 | -38 | -6 | -3 | |
Net Change | -3 | -4 | -1 | 0 | 0 | 3 | -1 | 7 | -1 | -5 | |
Cash & Cash Eqvt | 9 | 5 | 4 | 3 | 3 | 7 | 5 | 12 | 11 | 7 |
Fri, 06 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Pursuant to provision of Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations 2018 we hereby submit the confirmation certificate received from Link Intime India Private Limited Registrar and Share Transfer Agent (RTA) for the Quarter Ended December 31 2022. |
Wed, 28 Dec 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Munjal Mahendrabhai Patel & PACs |
Thu, 22 Dec 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Munjal Mahendrabhai Patel & PACs |
Fri, 27 Jan 2023 |
|
|
|
|
|